Polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Case group: This group will be treated with Ferual Assafoetida (1 gram daily) for three weeks and discontinue the consumption for one week. Thereafter, patients will use the drugs for
Sponsors
Shahed University
Eligibility
Sex/Gender
Female
Age
15 Years to 40 Years
Inclusion criteria
Inclusion criteria: All 15 to 40 years old women with polycystic ovarian syndrome
Exclusion criteria
Exclusion criteria: Pregnancy Allergy to Ferula Asafoetida Diabetic patients Thyroid diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of ovarian cysts. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: Sonography.;Occurrence of menstrual bleeding. Timepoint: 4 and 8 weeks after the beginning of treatment. Method of measurement: asking.;Hirsutism. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: Ferriman–Gallwey scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: Meter and scale.;Total Testosterone. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: CLIA laboratory method.;Free Testosterone. Timepoint: Before Intervention and seven days after Intervention. Method of measurement: ELIZA laboratory method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNajmeh Dehparvar
Shahed University
Outcome results
None listed